Main research interest: novel therapeutic approaches for the treatment of metabolic diseases, pain, cancer and neurodegeneration

Novel cannabinoid CB1 and CB2 receptor ligands
New putative cannabinoid GPR55 ligands
Novel PPAR receptor ligands
Dual acting drugs
back to IQM